Loading…
Satellos Bioscience is projected to rise to $9.69 by 2027, a +33% move from its current price of $7.28. MSLE is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $6.97 | $7.28 | $7.61 | +0.01% |
| May 30 | $6.85 | $7.28 | $7.74 | +0.03% |
| May 31 | $6.75 | $7.28 | $7.85 | +0.04% |
| Jun 1 | $6.68 | $7.28 | $7.95 | +0.06% |
| Jun 2 | $6.61 | $7.29 | $8.03 | +0.07% |
| Jun 3 | $6.55 | $7.29 | $8.11 | +0.09% |
| Jun 4 | $6.49 | $7.29 | $8.18 | +0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.49 | $7.29 | $8.18 | +0.10% |
| Week 2 | $6.20 | $7.29 | $8.59 | +0.20% |
| Week 3 | $5.98 | $7.30 | $8.92 | +0.30% |
| Week 4 | $5.80 | $7.31 | $9.20 | +0.40% |
| Week 5 | $5.65 | $7.32 | $9.47 | +0.50% |
| Week 6 | $5.52 | $7.32 | $9.71 | +0.60% |
| Week 7 | $5.40 | $7.33 | $9.94 | +0.70% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Satellos Bioscience Inc., symbol MSLE, is a clinical-stage drug development company focused on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. It leverages its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. Satellos is developing SAT-3247, an oral, small molecule drug candidate for Duchenne muscular dystrophy, and has a license agreement with the Ottawa Hospital Research Institute (OHRI) and an option agreement with the University of British Columbia.
Satellos was founded in 2018 and is headquartered in Toronto, Canada.
Satellos Bioscience Inc. (MSLE) currently trades at $7.28 per share and has a market cap of $141.76M. It ranks 5495. The near-term technical backdrop sits alongside the current price, with a 30-day range from $5.46 to $9.70 and a neutral stance on momentum.
A major floor 23.2% below — a decisive break under it would weaken the trend.
The nearest floor, 7.3% below — buyers have tended to step in here.
The nearest ceiling, 19.5% above — a clean break opens room to run.
A major ceiling 78.7% above — clearing it would confirm fresh momentum.
Key MSLE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MSLE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.07 | Buy | $7.07 | Buy |
| MA 10 | $7.09 | Buy | $7.13 | Buy |
| MA 20 | $7.37 | Sell | $7.24 | Buy |
| MA 50 | $7.12 | Buy | $7.58 | Sell |
| MA 100 | $8.62 | Sell | $7.76 | Sell |
| MA 200 | $7.29 | Sell | $7.43 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.66 | Neutral |
| Stoch RSI (14) | 85.65 | Sell |
| CCI (20) | -18.60 | Neutral |
| Williams %R (14) | -43.62 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -5.33 | Sell |
| Bollinger %B (20,2) | 0.44 | Neutral |
| Stochastic %K (14) | 56.38 | Neutral |
| TRIX (15) | -0.17 | Sell |
| Awesome (5,34) | -0.31 | Sell |
| Ultimate (7,14,28) | 51.56 | Neutral |
| Momentum (10) | 0.02 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 6.92 | Buy |
| ADX (14) | 9.98 | Neutral |
| ATR (14) | 0.30 | Info |
The 30-day technical picture shows a NEUTRAL stance, with RSI14 at 50, a SMA50 of $7.12 and a SMA200 of $7.29. The 30-day range runs from $5.46 to $9.70, reflecting light-to-moderate price movement.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.59 | $7.28 | $11.25 | 0% | Neutral | |
| $7.24 | $9.69 | $13.95 | +33% | Bullish | |
| $7.18 | $10.06 | $15.27 | +38% | Bullish | |
| $7.41 | $10.80 | $17.08 | +48% | Bullish | |
| $7.57 | $11.44 | $18.72 | +57% | Bullish | |
| $8.25 | $12.88 | $21.70 | +77% | Bullish | |
| $11.13 | $17.94 | $31.04 | +146% | Bullish | |
| $11.85 | $19.67 | $34.85 | +170% | Bullish | |
| $11.50 | $19.65 | $35.58 | +170% | Bullish | |
| $11.65 | $20.47 | $37.83 | +181% | Bullish | |
| $16.47 | $33.01 | $66.28 | +353% | Bullish | |
| $33.09 | $73.52 | $166.23 | +910% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $5.59 | $7.28 | $8.58 | +0.00% |
| June 2026 | $5.93 | $7.06 | $8.66 | -3.05% |
| July 2026 | $6.12 | $7.38 | $9.24 | +4.51% |
| August 2026 | $6.43 | $7.84 | $9.98 | +6.23% |
| September 2026 | $6.35 | $7.81 | $10.07 | -0.36% |
| October 2026 | $6.34 | $7.86 | $10.26 | +0.67% |
| November 2026 | $6.66 | $8.32 | $10.98 | +5.91% |
| December 2026 | $6.72 | $8.45 | $11.25 | +1.53% |
Click any year to see its month-by-month MSLE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The MSLE price prediction for 2026 points to an average of $7.28 (low $5.59, high $11.25) — a potential gain of 0% on today's $7.28. Price action looks broadly range-bound.
In 2027, MSLE is projected to trade between $7.24 and $13.95, averaging $9.69 — a potential gain of +33% from today's $7.28. That is up +33% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Satellos Bioscience's 2028 outlook centres on $10.06, within a $7.18 to $15.27 range. That is up +4% on the projected 2027 average. That marks a +38% change versus current levels. Momentum favours further upside here.
By 2029, MSLE could reach as high as $17.08, with a base case around $10.80 and support toward $7.41 — roughly +48% from $7.28. Buyers look set to stay in control over this stretch.
Expect MSLE to range from $7.57 to $18.72 through 2030. The $11.44 average target implies a +57% move from current prices. That is up +6% on the projected 2029 average. Momentum favours further upside here.
The MSLE price prediction for 2031 points to an average of $12.88 (low $8.25, high $21.70) — a potential gain of +77% on today's $7.28. Buyers look set to stay in control over this stretch.
In 2032, MSLE is projected to trade between $11.13 and $31.04, averaging $17.94 — a potential gain of +146% from today's $7.28. That is up +39% on the projected 2031 average. Momentum favours further upside here.
Satellos Bioscience's 2033 outlook centres on $19.67, within a $11.85 to $34.85 range. That is up +10% on the projected 2032 average. That marks a +170% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, MSLE could reach as high as $35.58, with a base case around $19.65 and support toward $11.50 — roughly +170% from $7.28. Momentum favours further upside here.
Expect MSLE to range from $11.65 to $37.83 through 2035. The $20.47 average target implies a +181% move from current prices. That is up +4% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The MSLE price prediction for 2040 points to an average of $33.01 (low $16.47, high $66.28) — a potential gain of +353% on today's $7.28. Momentum favours further upside here.
In 2050, MSLE is projected to trade between $33.09 and $166.23, averaging $73.52 — a potential gain of +910% from today's $7.28. That is up +123% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MSLE today (≈ 137.362637 MSLE) could be worth
$10,099.36
+$9,099.36 (+910%) by 2050 · US Dollar
Based on the average projected MSLE price of $73.52 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MSLEwould be worth at today's price.
$1,000 invested in MSLE on May 27, 2025 (≈ 163.398696 MSLE) would be worth
$1,189.54
+$189.54 (+19.0%) today · 1.19× · US Dollar
Based on a MSLE entry price of $6.12 vs. today's $7.28.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.36 | $989.8 | -1.0% |
| 1 month ago | $7.16 | $1,016.76 | +1.7% |
| 3 months ago | $11.66 | $624.36 | -37.6% |
| 6 months ago | $6.2 | $1,173.44 | +17.3% |
| 1 year ago | $6.12 | $1,189.54 | +19.0% |
| All time (5.0y) ago | $18.72 | $388.89 | -61.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MSLE forecast.
Our base-case forecast reaches $15.00 around 2032.
Implied market cap at $15.00: $312.47M
The multi-year forecast flips to bullish in 2027 and remains strong through 2050. In 2026, the average price is $7.28 with a min of $5.59 and a max of $11.25 (ROI 0). By 2030 the average is $11.44 (min $7.57, max $18.72) with a 57.1% ROI.
The years 2040 and 2050 show substantial upside, with an average price of $33.01 (min $16.47, max $66.28) and $73.52 (min $33.09, max $166.23), delivering ROIs of 353.4% and 909.9%, respectively. Across 2027–2035 the sentiment is bullish, with steadily rising averages and higher upper bounds, indicating meaningful upside potential while recognizing the inherent uncertainty of forward estimates.
Tap a question to reveal the answer.
2030 forecast—average price $11.44 with a min of $7.57 and a max of $18.72; ROI 57.1%; sentiment BULLISH.
Forecasts show a shift from NEUTRAL in 2026 to BULLISH from 2027 onward, with 2030 average $11.44 (ROI 57.1%), 2040 average $33.01 (ROI 353.4%), and 2050 average $73.52 (ROI 909.9%). These are estimates, not guarantees, and include risk.
Yes. The 2050 forecast includes a max of $166.23, which exceeds $100.
Current price is $7.28 and market cap is $141.76M.
The 30-day range is $5.46 to $9.70. RSI14 is 50, SMA50 is $7.12, SMA200 is $7.29. Support is $6.75 and resistance is $8.70, with annualized volatility at 80%.
Satellos Bioscience Community Discussion
0Share your Satellos Bioscience price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.